浙江佐力药业股份有限公司
Climate Impact & Sustainability Data (2023-01 to 2023-06)
Reporting Period: 2023-01 to 2023-06
Environmental Metrics
ESG Focus Areas
- Environmental Protection
- Social Responsibility
- Corporate Governance
Environmental Achievements
- Implemented ISO14001 environmental management system for nearly 20 years.
- Increased application of photovoltaic power generation technology and promoted clean energy use.
Social Achievements
- Organized various employee welfare activities.
- Implemented safety production month activities, including emergency rescue training and fire safety knowledge training.
- Actively participated in community public welfare activities.
- 100% product inspection pass rate and 100% product complaint handling rate.
Governance Achievements
- Improved corporate governance by strictly adhering to laws, regulations, and industry requirements.
- Strengthened risk control and internal control, including information security, anti-corruption, intellectual property protection, and party building.
- Published 9 investor relations activity records.
Climate Goals & Targets
Environmental Challenges
- Changes in industry policies (e.g., medical insurance adjustments, volume-based procurement, medical insurance cost control).
- Risks in drug R&D (high investment, multiple stages, long development cycle, high risk).
- Goodwill impairment risk (due to high acquisition prices).
Mitigation Strategies
- Closely monitor industry policy changes and adjust business strategies accordingly.
- Increase R&D investment, optimize innovation mechanisms, and improve R&D evaluation and decision-making systems.
- Strengthen cooperation with research institutions and improve the operation and management of subsidiaries.
Supply Chain Management
Climate-Related Risks & Opportunities
Awards & Recognition
- 2022 年度科技创新火炬奖
- 2022 年度中国中药企业 TOP100 排行榜
- 2022 年中国医药工业最具成长力企业
- 2022 年中成药综合竞争力 50 强
- 2022 年度最具社会责任(ESG)上市公司
- 2022 年度中国上市公司 ESG 百强企业